Fractional exhaled Nitric Oxide (FeNO) is widely used in both primary and secondary care settings across the world. Many ...

Patients with bronchial asthma suffer from attacks of shortness of breath caused by constricted airways. "Anti-inflammatory ...

Asthma severity can be affected by multiple inflammatory pathways, which make it challenging to treat with a “one size fits all” approach. This is why researchers started pursuing precision medicine ...

Among patients with severe asthma receiving dupilumab for 12 months, 91% had a clinical response and 30% achieved clinical remission.

A digital asthma self-management program enhanced symptom control; however, it revealed racial disparities in engagement, highlighting the need for culturally tailored interventions.

Prioritising disease control and embracing sustainable inhaler innovations will be key to delivering a net zero NHS, writes Edward Piper, medical & scientific affairs director at AstraZeneca UK ...